[1] American Diabetes Association. 12. older adults: standards of medical care in diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1): S139-S147. [2] Cruz-Jentoft A J, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(1): 16-31. [3] 米颖馨, 王欣, 张开, 等. 中老年男性2型糖尿病患者尿酸水平与肌少症的相关性研究[J]. 首都医科大学学报, 2021, 42(3): 453-458. [4] Anagnostis P, Gkekas N K, Achilla C, et al. Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis[J]. Calcif Tissue Int, 2020, 107(5): 453-463. [5] Beaudart C, Zaaria M, Pasleau F, et al. Health outcomes of sarcopenia: a systematic review and meta-analysis[J]. Plos One, 2017, 12(1): e0169548. [6] 李亚奥, 修双玲, 王立. 中老年男性2型糖尿病患者肌少症与骨密度的相关性研究[J]. 首都医科大学学报, 2020, 41(1): 119-124. [7] Cruz-Jentoft A J, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing,2019,48(1):16-31. [8] Chen L K, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307. [9] Studenski S A, Peters K W, Alley D E, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates[J]. J Gerontol A Biol Sci Med Sci,2014,69(5):547-558. [10] Tang T C, Hwang A C, Liu L K, et al. FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-Lan longitudinal aging study[J]. J Gerontol A Biol Sci Med Sci, 2018, 73(6): 828-834. [11] Prado C M M, Wells J C K, Smith S R, et al. Sarcopenic obesity: a critical appraisal of the current evidence[J]. Clin Nutr, 2012, 31(5): 583-601. [12] Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553. [13] Xiu S L, Mu Z J, Zhao L, et al. Low free triiodothyronine levels are associated with risk of frailty in older adults with type 2 diabetes mellitus[J]. Exp Gerontol, 2020, 138: 111013. [14] Baker J F, Long J, Leonard M B, et al. Estimation of skeletal muscle mass relative to adiposity improves prediction of physical performance and incident disability[J]. J Gerontol A Biol Sci Med Sci, 2018, 73(7): 946-952. [15] Sarkisian C A, Liu H, Gutierrez P R, et al. Modifiable risk factors predict functional decline among older women: a prospectively validated clinical prediction tool. The Study of Osteoporotic Fractures Research Group[J]. J Am Geriatr Soc, 2000, 48(2): 170-178. [16] Visser M, Langlois J, Guralnik J M, et al. High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study[J]. Am J Clin Nutr, 1998, 68(3): 584-590. [17] Delmonico M J, Harris T B, Lee J S, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women[J]. J Am Geriatr Soc, 2007, 55(5): 769-774. [18] 孙丽娜, 修双玲, 穆志静, 等. 贫血与老年2型糖尿病患者衰弱的相关性分析[J]. 中华实用诊断与治疗杂志, 2020, 34(9): 936-939. |